| Literature DB >> 28326139 |
Arno Verlee1, Thomas Heugebaert1, Tom van der Meer2, Pavel I Kerchev2, Frank Van Breusegem2, Christian V Stevens1.
Abstract
For the synthesis of m-sulfamoylbenzamide analogues, small molecules which are known for their bioactivity, a chemoselective procedure has been developed starting from m-(chlorosulfonyl)benzoyl chloride. Although a chemoselective process in batch was already reported, a continuous-flow process reveals an increased selectivity at higher temperatures and without catalysts. In total, 15 analogues were synthesized, using similar conditions, with yields ranging between 65 and 99%. This is the first automated and chemoselective synthesis of m-sulfamoylbenzamide analogues.Entities:
Keywords: flow chemistry; m-sulfamoylbenzamide analogues; medium-throughput synthesis
Year: 2017 PMID: 28326139 PMCID: PMC5331323 DOI: 10.3762/bjoc.13.33
Source DB: PubMed Journal: Beilstein J Org Chem ISSN: 1860-5397 Impact factor: 2.883
Figure 1m-Sulfamoylbenzamides as Sirtuin 2 inhibitors (SIRT2) or suppressor of polyglutamine aggregation (polyQ).
Screening results of the different conditions for the best chemoselectivity with aniline and azepane as (F2) and (F3), respectively.
| Run | Flow rate 1 (µL/min) | Flow rate 2 (µL/min) | Chemoselectivity (%) | |
| 1 | 50 | 100 | 0 | 91 |
| 2 | 75 | 150 | 0 | 80 |
| 3 | 25 | 50 | 10 | 89 |
| 4 | 50 | 100 | 10 | 91 |
| 5 | 75 | 150 | 10 | 93 |
| 6 | 100 | 200 | 10 | 92 |
| 7 | 125 | 250 | 10 | 89 |
| 8 | 75 | 150 | 20 | 92 |
| 9 | 100 | 200 | 20 | 93 |
| 10 | 125 | 250 | 20 | 94 |
| batch | – | – | 0 | 80a |
| batch | – | – | 20 | 75a |
aReaction performed in batch with a final concentration of 10 mM.
Screening results of the different conditions for the best chemoselectivity with azepane as (F2).
| Run | Flow rate (µL/min) | Concentration F1 and F2 (mM) | Final concentration (mM) | ||
| 1 | 50 | 40 | 20 | 29 | 36 |
| 2 | 100 | 40 | 20 | 29 | 36 |
| 3 | 200 | 40 | 20 | 28 | 36 |
| 4 | 50 | 20 | 10 | 37 | 32 |
| 5 | 100 | 20 | 10 | 60 | 20 |
| 6 | 150 | 20 | 10 | 47 | 27 |
| 7 | 100 | 10 | 5 | 63 | 19 |
| 8 | 150 | 10 | 5 | 71 | 15 |
| 9 | 200 | 10 | 5 | 64 | 18 |
| 10 | 200 | 5 | 2.5 | 67 | 17 |
| 11 | 400 | 5 | 2.5 | 74 | 13 |
| 12 | 600 | 5 | 2.5 | 82 | 9 |
Screening results of the different conditions for the best chemoselectivity with azepane and aniline as (F2) and (F3), respectively.
| Run | Flow rate 1 (µL/min) | Flow rate 2 (µL/min) | Chemoselectivity (%) | |
| 1 | 300 | 600 | −15 | 39 |
| 2 | 400 | 800 | −15 | 79 |
| 3 | 500 | 1000 | −15 | 57 |
| 4 | 300 | 600 | 0 | 53 |
| 5 | 400 | 800 | 0 | 80 |
| 6 | 500 | 1000 | 0 | 82 |
| 7 | 600 | 1200 | 0 | 52 |
| 8 | 200 | 400 | 10 | 41 |
| 9 | 300 | 600 | 10 | 50 |
| 10 | 400 | 800 | 10 | 40 |
| batch | – | – | 0 | 59a |
aReaction performed in batch with a final concentration of 1.25 M.
Chemoselectivity (%) of the medium-throughput synthesis in continuous flow.
| (F3) | |||||||||
| (F2) | |||||||||
| 99 | 94 | 95 | 64 | 95 | 83 | 94 | |||
| 82 | 99 | 83 | 77 | 76 | 70 | 74 | |||
| 83 | 94 | 99 | 64 | 94 | 84 | 97 | |||
| 64 | 59 | 53 | 99 | 58 | 68 | 85 | |||
| 93 | 94 | 94 | 63 | 99 | 86 | 94 | |||
| 77 | 73 | 71 | 50 | 77 | 99 | 72 | |||
| 68 | 69 | 83 | 63 | 60 | 61 | 99 | |||
Library of 15 m-sulfamoylbenzamide analogues synthesized in continuous flow.
| Compound | (F2) | (F3) | Chemoselectivity (%) | Yield (%) | Quantity (mg) |
| – | 95 | 140 | |||
| 94 | 75 | 197 | |||
| 95 | 78 | 94 | |||
| 95 | 76 | 92 | |||
| 94 | 74 | 88 | |||
| 83 | 70 | 83 | |||
| 94 | 78 | 93 | |||
| – | 99 | 97 | |||
| 94 | 81 | 77 | |||
| 97 | 77 | 96 | |||
| 93 | 80 | 96 | |||
| 94 | 78 | 94 | |||
| 94 | 72 | 87 | |||
| – | 98 | 117 | |||
| 94 | 77 | 93 | |||
aReduced chemoselectivity due to leakage during the reaction.
Figure 2Syrris AFRICA system.